HC Deb 13 March 1995 vol 256 c399W
Mr. Barry Field

To ask the Secretary of State for Health (1) what further representations she has received about arachnoiditis and the use of Depo-Medrone;

(2) if she will make a statement on arachnoidits.

Mr. Sackville

We have received a number of representations about Depo-Medrone and arachnoiditis. Depo-Medrone is licensed for use by certain specified routes of administration only and is not recommended for epidural or spinal administration. If a doctor, however, believes that use of a licensed drug in an unlicensed manner is the only suitable treatment for a patient he or she may supply or administer the drug, having obtained informed consent from the patient.